AU2001255439A1 - Method of treating alzheimer's disease - Google Patents

Method of treating alzheimer's disease

Info

Publication number
AU2001255439A1
AU2001255439A1 AU2001255439A AU5543901A AU2001255439A1 AU 2001255439 A1 AU2001255439 A1 AU 2001255439A1 AU 2001255439 A AU2001255439 A AU 2001255439A AU 5543901 A AU5543901 A AU 5543901A AU 2001255439 A1 AU2001255439 A1 AU 2001255439A1
Authority
AU
Australia
Prior art keywords
disease
treating alzheimer
alzheimer
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255439A
Inventor
Carol A. Colton
Meggan Czapiga
Michael P Vitek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Georgetown University
Duke University
Original Assignee
Georgetown University
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georgetown University, Duke University filed Critical Georgetown University
Publication of AU2001255439A1 publication Critical patent/AU2001255439A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001255439A 2000-04-17 2001-04-16 Method of treating alzheimer's disease Abandoned AU2001255439A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19758400P 2000-04-17 2000-04-17
US60197584 2000-04-17
PCT/US2001/012496 WO2001078715A1 (en) 2000-04-17 2001-04-16 Method of treating alzheimer's disease

Publications (1)

Publication Number Publication Date
AU2001255439A1 true AU2001255439A1 (en) 2001-10-30

Family

ID=22729979

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255439A Abandoned AU2001255439A1 (en) 2000-04-17 2001-04-16 Method of treating alzheimer's disease

Country Status (2)

Country Link
AU (1) AU2001255439A1 (en)
WO (1) WO2001078715A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2041078A4 (en) * 2006-06-23 2016-06-01 The Feinstein Inst Medical Res INHIBITORS OF Abeta AND SYNUCLEIN AGGREGATION

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028627A (en) * 1989-09-13 1991-07-02 Cornell Research Foundation, Inc. Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
US5585402A (en) * 1992-12-23 1996-12-17 Glaxo Wellcome Inc. Nitric oxide synthase inhibitors
US5599984A (en) * 1994-01-21 1997-02-04 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions

Also Published As

Publication number Publication date
WO2001078715A1 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
AU2001233299A1 (en) Methods for treating alzheimer's disease
AU2001273132A1 (en) Compounds to treat alzheimer's disease
AU1407399A (en) Treatment for alzheimer's disease
AU2001249835A1 (en) Diagnosis and treatment of alzheimer's disease
AU2002306848A1 (en) Methods of treating alzheimer's disease with piperidin derivates
AU2002319615A1 (en) Methods for diagnosing and treating alzheimer's disease and parkinson's disease
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
AU2002246490A1 (en) Method of treating parkinson's disease
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
AU2002239765A1 (en) Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
AU2001236592A1 (en) Methods for diagnosis of alzheimer's disease
PL339910A1 (en) Method of treating alzheimer disease
AU2001286983A1 (en) Method of treatment
AU2001273661A1 (en) Methods of screening for alzheimer's disease
AU2002302238A1 (en) A method of treatment of alzheimer's disease and device therefor
AU2002222108A1 (en) Diagnosis and treatment of alzheimer's disease
AU1405899A (en) Treatment for alzheimer's disease
EP1181550A4 (en) Methods for the identification of compounds for the treatment of alzheimer's disease
AU2002303957A1 (en) Method of treating alzheimer's disease with se-containing peptide
AU2002220372A1 (en) Method for screening for inhibitors of alzheimer's disease
AU2001262177A1 (en) Method of treatment
AU2001255439A1 (en) Method of treating alzheimer's disease
AU2002303988A1 (en) Methods of treating alzheimer's disease
AU2003230848A1 (en) Methods and compositions for treating alzheimer's disease
AU2001279643A1 (en) A method of treatment of alzheimer's disease with a protein extractable from mammalian organs